NCT05068115

Brief Summary

To describe the clinical characteristics, the diagnosis and treatment, the survival status and change trend of young breast cancer patients in China from 2000 to 2015, and to explore and discuss the main influencing factors.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2021

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 15, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 5, 2021

Completed
27 days until next milestone

Study Start

First participant enrolled

November 1, 2021

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
Last Updated

October 13, 2021

Status Verified

October 1, 2021

Enrollment Period

1.9 years

First QC Date

August 15, 2021

Last Update Submit

October 12, 2021

Conditions

Breast Cancer

Outcome Measures

Primary Outcomes (3)

  • Clinical features and trend

    To describe the clinical characteristics and trends of young breast cancer patients in China

    Between 2000 and 2015

  • Diagnosis and treatment and trend

    To describe the methods of diagnosis and treatment in young breast cancer patients in China and the changing trend, to explore the main factors affecting diagnosis and treatment

    Between 2000 and 2015

  • Survival situation and change trend

    To describe the survival and change trend of young breast cancer patients in China, to explore the main factors affecting the prognosis of young breast cancer patients

    Between 2000 and 2015

Study Arms (1)

1

Young breast cancer patients in China from 2000 to 2015, of whom the clinical features, diagnosis and treatment models and survival status are described.

Procedure: Clinical characteristics, diagnosis and treatment, survival status

Interventions

Clinical characteristics, diagnosis and treatment, survival statusPROCEDURE

Describe the clinical characteristics, diagnosis and treatment, survival status and the trends of young breast cancer

Also known as: This is a retrospective study to observe and describe the diagnosis and treatment of previous young breast cancer patients without intervention
1

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Young Breast cancer patients (≤35 years old) in China

You may qualify if:

  • Young Breast cancer patients (≤35 years old) in China

You may not qualify if:

  • Breast cancer patients (\>35 years old) in China

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Breast Neoplasms

Interventions

TherapeuticsMethods

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 15, 2021

First Posted

October 5, 2021

Study Start

November 1, 2021

Primary Completion

October 1, 2023

Study Completion

October 1, 2024

Last Updated

October 13, 2021

Record last verified: 2021-10